Urology and surgical company Imagyn Medical Technologies of Newport Beach, CA, filed for Chapter 11 bankruptcy protection last week in an effort to preempt a group of creditors that has been trying to force the company into involuntary bankruptcy.
Urology and surgical company Imagyn Medical Technologies of Newport Beach, CA, filed for Chapter 11 bankruptcy protection last week in an effort to preempt a group of creditors that has been trying to force the company into involuntary bankruptcy. Imagyn executives said they plan to develop a reorganization plan for the company and solicit new financing to get the firm back on its feet. While Imagyn doesnt participate directly in the radiology segment, the company does have OEM relationships with several medical imaging companies, including International Isotopes and Fischer Imaging.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.